These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20938175)

  • 1. A phase II study of antofloxacin hydrochloride, a novel fluoroquinolone, for the treatment of acute bacterial infections.
    Wang J; Xiao Y; Huang W; Xu N; Bai C; Xiu Q; Mei C; Zheng Q
    Chemotherapy; 2010; 56(5):378-85. PubMed ID: 20938175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
    Urueta-Robledo J; Ariza H; Jardim JR; Caballero A; García-Calderón A; Amábile-Cuevas CF; Hernández-Oliva G; Vivar-Orozco R;
    Respir Med; 2006 Sep; 100(9):1504-11. PubMed ID: 16504492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.
    Niederman MS; Anzueto A; Sethi S; Choudhri S; Kureishi A; Haverstock D; Perroncel R
    Respir Med; 2006 Oct; 100(10):1781-90. PubMed ID: 16531032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
    Kahn JB; Khashab M; Ambruzs M
    Curr Med Res Opin; 2007 Jan; 23(1):1-7. PubMed ID: 17261234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of single and multiple oral dose administration of antofloxacin hydrochloride in healthy male volunteers.
    Lü Y; Kang ZS; Zhu Y; Zhang M; Liu Y; Zhang M; Li TY; Xiao YH
    Chin Med J (Engl); 2011 Jan; 124(2):242-5. PubMed ID: 21362374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis.
    Nicolau DP; Sutherland C; Winget D; Baughman RP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):94-8. PubMed ID: 22210007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A multi-center, randomized, controlled, double blind and double dummy clinical trial of antofloxacin hydrochloride tablet versus levofloxacin tablet for the treatment of acute bacterial infections].
    Xiao YH; Cui H; Xue F; Huang WX; Xiu QY; Li DT; Chen P; Jia ZP; Wen AD; Yang GP; Mao GG
    Zhonghua Nei Ke Za Zhi; 2011 Mar; 50(3):225-9. PubMed ID: 21600087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection.
    Xiao XM; Xiao YH
    Acta Pharmacol Sin; 2008 Oct; 29(10):1253-60. PubMed ID: 18817632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
    Martinez FJ; Anzueto A
    Am J Med; 2005 Jul; 118 Suppl 7A():39S-44S. PubMed ID: 15993676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of ofloxacin and pivmecillinam in acute exacerbations of chronic bronchitis.
    Egede F; Kristensen I
    Scand J Infect Dis Suppl; 1990; 68():46-9. PubMed ID: 2218422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
    Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P; Dobryniewska M; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
    Starakis I; Gogos CA; Bassaris H
    Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute exacerbation of chronic bronchitis. Guidelines for antibiotic selection.
    Schwarzmann SW
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):25-9. PubMed ID: 19667546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.
    Milstone A; Patsimas J; Farzan D; Castaldo R; Singh H; Feurer I; Harnett J; Luke DR;
    Clin Ther; 2005 Jun; 27(6):926-39. PubMed ID: 16117993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre surveillance study on the characteristics, bacterial aetiologies and in vitro antibiotic susceptibilities in patients with acute exacerbations of chronic bronchitis.
    Hui DS; Ip M; Ling T; Chang SC; Liao CH; Yoo CG; Kim DK; Yoon HI; Udompanich V; Mogmeud S; Muttalif R; Salleh AM; Roa C; Mendoza M; Fajardo-Ang C; Soepandi P; Isbaniah F; Burhan E; Sudarmono P; Mangunnegoro H; Liu HH
    Respirology; 2011 Apr; 16(3):532-9. PubMed ID: 21299688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK; Triller DM; Yong CS; Lodise TP
    Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.